{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:51:06Z","timestamp":1777618266590,"version":"3.51.4"},"reference-count":156,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003093","name":"Malaysia Ministry of Higher Education","doi-asserted-by":"publisher","award":["FRGS\/1\/2019\/STG01\/UKM\/02\/3"],"award-info":[{"award-number":["FRGS\/1\/2019\/STG01\/UKM\/02\/3"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.bioorg.2024.107510","type":"journal-article","created":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T23:06:04Z","timestamp":1717023964000},"page":"107510","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Exploring antimalarial potential: Conjugating organometallic moieties with organic fragments for enhanced efficacy"],"prefix":"10.1016","volume":"149","author":[{"given":"Nur","family":"Aqilah Zahirah Norazmi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nur","family":"Hafizah Mukhtar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lekkala","family":"Ravindar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aimi","family":"Suhaily Saaidin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nurul","family":"Huda Abd Karim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amatul","family":"Hamizah Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hani","family":"Kartini Agustar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norzila","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lau","family":"Yee Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Ebihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nurul","family":"Izzaty Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2024.107510_b0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1756-3305-3-5","article-title":"History of discovering the malaria parasites and their vectors","volume":"3","author":"Cox","year":"2010","journal-title":"Parasit. Vectors."},{"key":"10.1016\/j.bioorg.2024.107510_b0010","doi-asserted-by":"crossref","first-page":"17050","DOI":"10.1038\/nrdp.2017.50","article-title":"Malaria","volume":"3","author":"Phillips","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.bioorg.2024.107510_b0015","first-page":"1","article-title":"Emergency department management of mosquito-borne illness: malaria, dengue, and West Nile virus","volume":"16","author":"Caraballo","year":"2014","journal-title":"Emerg. Med. Pract."},{"key":"10.1016\/j.bioorg.2024.107510_b0020","unstructured":"World Health Organization (WHO), World Malaria Report 2023, Geneva, 2023. https:\/\/www.who.int\/teams\/global-malaria-programme\/reports\/world-malaria-report-2023."},{"key":"10.1016\/j.bioorg.2024.107510_b0025","doi-asserted-by":"crossref","first-page":"e214","DOI":"10.1016\/S2666-5247(24)00016-8","article-title":"The 2023 WHO World malaria report","volume":"5","author":"Venkatesan","year":"2024","journal-title":"Lancet Microbe."},{"key":"10.1016\/j.bioorg.2024.107510_b0030","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1021\/cr3001252","article-title":"Metalloantimalarials","volume":"113","author":"Salas","year":"2013","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2024.107510_b0035","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.2147\/IDR.S279433","article-title":"Antimalarial drug resistance and novel targets for antimalarial drug discovery","volume":"13","author":"Shibeshi","year":"2020","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.bioorg.2024.107510_b0040","series-title":"Plasmodium Species Drug Resist","first-page":"13","article-title":"Plasmodium species and drug resistance","author":"Tseha","year":"2021"},{"key":"10.1016\/j.bioorg.2024.107510_b0045","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1182\/blood-2010-04-202911","article-title":"The pathogenesis of Plasmodium falciparum malaria in humans: insights from splenic physiology","volume":"117","author":"Buffet","year":"2011","journal-title":"Blood."},{"key":"10.1016\/j.bioorg.2024.107510_b0050","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0140-6736(13)60024-0","article-title":"Malaria","volume":"383","author":"White","year":"2014","journal-title":"Lancet."},{"key":"10.1016\/j.bioorg.2024.107510_b0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01444","article-title":"Sticking for a cause: the falciparum malaria parasites cytoadherence paradigm","volume":"10","author":"Lee","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioorg.2024.107510_b0060","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nrmicro3138","article-title":"Antimalarial drug discovery \u2014 approaches and progress towards new medicines","volume":"11","author":"Flannery","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bioorg.2024.107510_b0065","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.sajb.2019.11.017","article-title":"A literature review on traditional herbal medicines for malaria","volume":"128","author":"Noronha","year":"2020","journal-title":"South African J. Bot."},{"key":"10.1016\/j.bioorg.2024.107510_b0070","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4269\/ajtmh.15-0007","article-title":"Antimalarial drug resistance: literature review and activities and findings of the ICEMR network","volume":"93","author":"Cui","year":"2015","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.bioorg.2024.107510_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/microbiolspec.EI10-0013-2016","article-title":"Artemisinin-resistant plasmodium falciparum malaria","volume":"4","author":"Fairhurst","year":"2016","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.bioorg.2024.107510_b0080","doi-asserted-by":"crossref","DOI":"10.1007\/s15010-024-02196-y","article-title":"Malaria vaccine efficacy, safety, and community perception in Africa: a scoping review of recent empirical studies","author":"Chutiyami","year":"2024","journal-title":"Infection."},{"key":"10.1016\/j.bioorg.2024.107510_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115458","article-title":"Recent developments in antimalarial activities of 4-aminoquinoline derivatives","volume":"256","author":"Ravindar","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115694","article-title":"Triazole hybrid compounds: A new frontier in malaria treatment","volume":"259","author":"Ravindar","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.116043","article-title":"Exploring diverse frontiers: Advancements of bioactive 4-aminoquinoline-based molecular hybrids in targeted therapeutics and beyond","volume":"264","author":"Ravindar","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2023.105573","article-title":"Structure-based design, and development of amidinyl, amidoximyl and hydroxamic acid based organic molecules as novel antimalarial drug candidates","volume":"17","author":"Adebayo","year":"2024","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106365","article-title":"Pyrazole and pyrazoline derivatives as antimalarial agents: A key review","volume":"183","author":"Ravindar","year":"2023","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2024.107510_b0110","series-title":"Bioinorg. Med. Chem.","first-page":"1","article-title":"Medicinal inorganic chemistry: state of the art, new trends, and a vision of the future","author":"Farrer","year":"2011"},{"key":"10.1016\/j.bioorg.2024.107510_b0115","series-title":"Bioinorg. Med. Chem.","first-page":"49","article-title":"Targeting strategies for metal-based therapeutics","author":"Norman","year":"2011"},{"key":"10.1016\/j.bioorg.2024.107510_b0120","first-page":"3239","article-title":"Synthesis and antimalarial activity of metal complexes of cross-bridged tetraazamacrocyclic ligands, Bioorganic","volume":"22","author":"Hubin","year":"2014","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0125","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1021\/jm950729w","article-title":"Toward a novel metal-based chemotherapy against tropical diseases. 2. Synthesis and antimalarial activity in vitro and in vivo of new ruthenium\u2212 and rhodium\u2212chloroquine complexes","volume":"39","author":"S\u00e1nchez-Delgado","year":"1996","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0130","unstructured":"Medicines for Malaria Venture, ZY19489-Ferroquine, (2024). https:\/\/www.mmv.org\/mmv-pipeline-antimalarial-drugs\/zy19489-ferroquine (accessed April 25, 2024)."},{"key":"10.1016\/j.bioorg.2024.107510_b0135","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202202411","article-title":"Development of mitochondria targeting AIE-active cyclometalated iridium complexes as potent antimalarial agents","volume":"12","author":"Kumari","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.bioorg.2024.107510_b0140","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202300158","article-title":"Synthesis, characterization, antimicrobial and antimalarial activities of azines based schiff bases and their Pd(II) complexes","volume":"20","author":"Meena","year":"2023","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.bioorg.2024.107510_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.inoche.2023.111473","article-title":"Exploring the antimalarial, antioxidant and antimicrobial properties of newly synthesized diorganotin(IV) complexes with ONO-donor hydrazone ligands","volume":"158","author":"Taxak","year":"2023","journal-title":"Inorg. Chem. Commun."},{"key":"10.1016\/j.bioorg.2024.107510_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/9414093","article-title":"Review of atypical organometallic compounds as antimalarial drugs","volume":"2020","author":"Kwofie","year":"2020","journal-title":"J. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0155","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202300326","article-title":"Transition metal complexes as antimalarial agents: A review","volume":"18","author":"Mandal","year":"2023","journal-title":"ChemMedChem."},{"key":"10.1016\/j.bioorg.2024.107510_b0160","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.3390\/molecules24193604","article-title":"Ferrocene-based compounds with antimalaria\/anticancer activity","volume":"24","author":"Peter","year":"2019","journal-title":"Molecules."},{"key":"10.1016\/j.bioorg.2024.107510_b0165","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ccr.2018.04.008","article-title":"Recent developments in the chemistry of ferrocenyl secondary natural product conjugates","volume":"366","author":"Kowalski","year":"2018","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.bioorg.2024.107510_b0170","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ejmech.2015.07.009","article-title":"Ferroquine and its derivatives: New generation of antimalarial agents","volume":"101","author":"Wani","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0175","doi-asserted-by":"crossref","first-page":"5276","DOI":"10.3390\/molecules25225276","article-title":"Recent advances in the biological investigation of organometallic platinum-group metal (Ir, Ru, Rh, Os, Pd, Pt) complexes as antimalarial agents","volume":"25","author":"Mbaba","year":"2020","journal-title":"Molecules."},{"key":"10.1016\/j.bioorg.2024.107510_b0180","series-title":"Targeting Sensitive-Strain and Resistant-Strain Malaria Parasites Through a Metal-Based Approach","author":"Baartzes","year":"2018"},{"key":"10.1016\/j.bioorg.2024.107510_b0185","doi-asserted-by":"crossref","first-page":"436","DOI":"10.2174\/1568026622666220105103751","article-title":"Structural-activity relationship of metallo-aminoquines as next generation antimalarials","volume":"22","author":"Abid","year":"2022","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0190","doi-asserted-by":"crossref","first-page":"8676","DOI":"10.1002\/chem.201904699","article-title":"Enhancing the activity of drugs by conjugation to organometallic fragments","volume":"26","author":"Chellan","year":"2020","journal-title":"Chem. \u2013 A Eur. J."},{"key":"10.1016\/j.bioorg.2024.107510_b0195","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1475-2875-6-81","article-title":"In vitro activity of ferroquine (SSR 97193) against Plasmodium falciparum isolates from the Thai-Burmese border","volume":"6","author":"Barends","year":"2007","journal-title":"Malar. J."},{"key":"10.1016\/j.bioorg.2024.107510_b0200","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1021\/mp0500061","article-title":"Insights into the mechanism of action of ferroquine. Relationship between physicochemical properties and antiplasmodial activity","volume":"2","author":"Biot","year":"2005","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bioorg.2024.107510_b0205","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ddtec.2019.06.001","article-title":"Organometallic compounds in drug discovery: Past, present and future","volume":"37","author":"Ong","year":"2020","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.bioorg.2024.107510_b0210","series-title":"Med. Organomet. Chem.","first-page":"155","article-title":"Bioorganometallic chemistry and malaria","author":"Biot","year":"2010"},{"key":"10.1016\/j.bioorg.2024.107510_b0215","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/cmdc.200700127","article-title":"Ferrocene conjugates of chloroquine and other antimalarials: the development of ferroquine, a new antimalarial","volume":"3","author":"Dive","year":"2008","journal-title":"ChemMedChem."},{"key":"10.1016\/j.bioorg.2024.107510_b0220","doi-asserted-by":"crossref","first-page":"6510","DOI":"10.1016\/j.bmc.2007.07.012","article-title":"Metallocene-based antimalarials: An exploration into the influence of the ferrocenyl moiety on in vitro antimalarial activity in chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum","volume":"15","author":"Blackie","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2008\/495123","article-title":"Metallocene antimalarials: the continuing quest","volume":"2008","author":"Blackie","year":"2008","journal-title":"Met. Based. Drugs."},{"key":"10.1016\/j.bioorg.2024.107510_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111791","article-title":"Current scenario of ferrocene-containing hybrids for antimalarial activity","volume":"185","author":"Xiao","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0235","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1021\/ic802220w","article-title":"Synthesis, characterization, and in vitro antimalarial and antitumor activity of new ruthenium(II) complexes of chloroquine","volume":"48","author":"Rajapakse","year":"2009","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0240","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1021\/jm970401y","article-title":"Synthesis and antimalarial activity in vitro and in vivo of a new ferrocene\u2212chloroquine analogue","volume":"40","author":"Biot","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0245","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1021\/jm9018383","article-title":"Antimalarial versus cytotoxic properties of dual drugs derived from 4-aminoquinolines and mannich bases: interaction with DNA","volume":"53","author":"Wenzel","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0250","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1055\/s-0031-1296211","article-title":"Synthesis and in vitro antiplasmodial activityof quinoline-ferrocene esters","volume":"61","author":"Da","year":"2011","journal-title":"Arzneimittelforschung."},{"key":"10.1016\/j.bioorg.2024.107510_b0255","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1007\/s00044-013-0748-4","article-title":"Synthesis, in vitro antiplasmodial and antiproliferative activities of a series of quinoline\u2013ferrocene hybrids","volume":"23","author":"N\u2019Da","year":"2014","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2024.107510_b0260","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1021\/jm301422h","article-title":"Structural characteristics of chloroquine-bridged ferrocenophane analogues of ferroquine may obviate malaria drug-resistance mechanisms","volume":"56","author":"Salas","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0265","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ejmech.2014.11.065","article-title":"Synthesis and in vitro antiplasmodial activity of ferrocenyl aminoquinoline derivatives","volume":"90","author":"Mwande-Maguene","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0270","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1021\/om300945c","article-title":"Synthesis, characterization, and pharmacological evaluation of silicon-containing aminoquinoline organometallic complexes as antiplasmodial, antitumor, and antimycobacterial agents","volume":"32","author":"Li","year":"2013","journal-title":"Organometallics."},{"key":"10.1016\/j.bioorg.2024.107510_b0275","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1021\/om500622p","article-title":"Synthesis and evaluation of a carbosilane congener of ferroquine and its corresponding half-sandwich ruthenium and rhodium complexes for antiplasmodial and \u03b2-hematin inhibition activity","volume":"33","author":"Li","year":"2014","journal-title":"Organometallics."},{"key":"10.1016\/j.bioorg.2024.107510_b0280","doi-asserted-by":"crossref","first-page":"19086","DOI":"10.1039\/C6DT03175G","article-title":"Bioisosteric ferrocenyl-containing quinolines with antiplasmodial and antitrichomonal properties","volume":"45","author":"Adams","year":"2016","journal-title":"Dalt. Trans."},{"key":"10.1016\/j.bioorg.2024.107510_b0285","doi-asserted-by":"crossref","first-page":"6431","DOI":"10.1039\/c2dt12050j","article-title":"1,2-Disubstituted ferrocenyl carbohydrate chloroquine conjugates as potential antimalarial agents","volume":"41","author":"Herrmann","year":"2012","journal-title":"Dalt. Trans."},{"key":"10.1016\/j.bioorg.2024.107510_b0290","doi-asserted-by":"crossref","first-page":"5736","DOI":"10.1021\/om300354x","article-title":"1,1\u2032-Disubstituted ferrocenyl carbohydrate chloroquine conjugates as potential antimalarials","volume":"31","author":"Herrmann","year":"2012","journal-title":"Organometallics."},{"key":"10.1016\/j.bioorg.2024.107510_b0295","doi-asserted-by":"crossref","first-page":"5748","DOI":"10.1021\/om300392q","article-title":"Modular synthesis of 1,2- and 1,1\u2032-disubstituted ferrocenyl carbohydrate chloroquine and mefloquine conjugates as potential antimalarial agents","volume":"31","author":"Herrmann","year":"2012","journal-title":"Organometallics."},{"key":"10.1016\/j.bioorg.2024.107510_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111963","article-title":"Design and synthesis of novel ferrocene-quinoline conjugates and evaluation of their electrochemical and antiplasmodium properties","volume":"187","author":"Mini\u0107","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0305","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jorganchem.2012.06.025","article-title":"Synthesis of 2-ferrocenylquinoline derivatives and evaluation of their antimalarial activity","volume":"716","author":"Patti","year":"2012","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0310","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1128\/AAC.05345-11","article-title":"Novel potent metallocenes against liver stage malaria","volume":"56","author":"Matos","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2024.107510_b0315","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1039\/C7MT00196G","article-title":"Platinum(<scp>ii<\/scp>)\u2013chloroquine complexes are antimalarial agents against blood and liver stages by impairing mitochondrial function","volume":"9","author":"Macedo","year":"2017","journal-title":"Metallomics."},{"key":"10.1016\/j.bioorg.2024.107510_b0320","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1039\/C7DT04142J","article-title":"Isomeric and hybrid ferrocenyl\/cyrhetrenyl aldimines: a new family of multifunctional compounds","volume":"47","author":"Oyarzo","year":"2018","journal-title":"Dalt. Trans."},{"key":"10.1016\/j.bioorg.2024.107510_b0325","first-page":"8085","article-title":"Synthesis and antimalarial activities of rhenium bioorganometallics based on the 4-aminoquinoline structure, Bioorganic","volume":"18","author":"Arancibia","year":"2010","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0330","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jinorgbio.2011.03.019","article-title":"Synthesis, characterization and antimalarial activity of new chromium arene-quinoline half sandwich complexes","volume":"105","author":"Glans","year":"2011","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.bioorg.2024.107510_b0335","doi-asserted-by":"crossref","first-page":"6443","DOI":"10.1039\/c2dt30077j","article-title":"Synthesis and biological activity of cymantrene and cyrhetrene 4-aminoquinoline conjugates against malaria, leishmaniasis, and trypanosomiasis","volume":"41","author":"Glans","year":"2012","journal-title":"Dalt. Trans."},{"key":"10.1016\/j.bioorg.2024.107510_b0340","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1039\/c2dt12083f","article-title":"Ruthenium(ii) arene complexes with chelating chloroquine analogue ligands: Synthesis, characterization and in vitro antimalarial activity","volume":"41","author":"Glans","year":"2012","journal-title":"Dalt. Trans."},{"key":"10.1016\/j.bioorg.2024.107510_b0345","doi-asserted-by":"crossref","first-page":"19314","DOI":"10.1039\/C5DT02410B","article-title":"Antimalarial activity of ruthenium(II) and osmium(II) arene complexes with mono- and bidentate chloroquine analogue ligands","volume":"44","author":"Ekengard","year":"2015","journal-title":"Dalton Trans."},{"key":"10.1016\/j.bioorg.2024.107510_b0350","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1039\/C5DT03739E","article-title":"Pentamethylcyclopentadienyl-rhodium and iridium complexes containing (N^N and N^O) bound chloroquine analogue ligands: synthesis, characterization and antimalarial properties","volume":"45","author":"Ekengard","year":"2016","journal-title":"Dalt. Trans."},{"key":"10.1016\/j.bioorg.2024.107510_b0355","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1039\/C6MD00251J","article-title":"Biological assessment of substituted quinoline based heteroleptic organometallic compounds","volume":"7","author":"Mehta","year":"2016","journal-title":"Medchemcomm."},{"key":"10.1016\/j.bioorg.2024.107510_b0360","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1017\/S0031182016001153","article-title":"Chloroquine-containing organoruthenium complexes are fast-acting multistage antimalarial agents","volume":"143","author":"Macedo","year":"2016","journal-title":"Parasitology."},{"key":"10.1016\/j.bioorg.2024.107510_b0365","doi-asserted-by":"crossref","first-page":"13143","DOI":"10.1039\/C9DT02030F","article-title":"N, O -Chelating quinoline-based half-sandwich organorhodium and -iridium complexes: synthesis, antiplasmodial activity and preliminary evaluation as transfer hydrogenation catalysts for the reduction of NAD +","volume":"48","author":"Stringer","year":"2019","journal-title":"Dalt. Trans."},{"key":"10.1016\/j.bioorg.2024.107510_b0370","article-title":"Antimalarial Agents Derived from Metal-Amodiaquine Complexes with Activity in Multiple Stages of the Plasmodium Life Cycle","volume":"29","author":"Colina-Vegas","year":"2023","journal-title":"Chem. \u2013 A Eur. J."},{"key":"10.1016\/j.bioorg.2024.107510_b0375","doi-asserted-by":"crossref","first-page":"14906","DOI":"10.1039\/C5DT02378E","article-title":"Polyamine quinoline rhodium complexes: synthesis and pharmacological evaluation as antiparasitic agents against Plasmodium falciparum and Trichomonas vaginalis","volume":"44","author":"Stringer","year":"2015","journal-title":"Dalt. Trans."},{"key":"10.1016\/j.bioorg.2024.107510_b0380","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.cell.2011.03.049","article-title":"Sickle Hemoglobin Confers Tolerance to Plasmodium Infection","volume":"145","author":"Ferreira","year":"2011","journal-title":"Cell."},{"key":"10.1016\/j.bioorg.2024.107510_b0385","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3390\/ijms20010039","article-title":"A Dual Role of Heme Oxygenase-1 in Cancer Cells","volume":"20","author":"Chiang","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2024.107510_b0390","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nm1586","article-title":"Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria","volume":"13","author":"Pamplona","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.bioorg.2024.107510_b0395","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S1474-4422(05)70247-7","article-title":"Pathogenesis, clinical features, and neurological outcome of cerebral malaria","volume":"4","author":"Idro","year":"2005","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bioorg.2024.107510_b0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2020.111328","article-title":"Diversification of quinoline-triazole scaffolds with CORMs: Synthesis, in vitro and in silico biological evaluation against Plasmodium falciparum","volume":"215","author":"Ishmail","year":"2021","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.bioorg.2024.107510_b0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2022.111905","article-title":"Rhenium(I) derivatives of aminoquinoline and imidazolopiperidine-based ligands: Synthesis, in vitro and in silico biological evaluation against Plasmodium falciparum","volume":"234","author":"Sovari","year":"2022","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.bioorg.2024.107510_b0410","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1051\/parasite\/2018021","article-title":"Plasmodium falciparum resistance to artemisinin-based combination therapies: A sword of Damocles in the path toward malaria elimination","volume":"25","author":"Ouji","year":"2018","journal-title":"Parasite."},{"key":"10.1016\/j.bioorg.2024.107510_b0415","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S1473-3099(21)00168-7","article-title":"Has artemisinin resistance emerged in Africa?","volume":"21","author":"Rosenthal","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.bioorg.2024.107510_b0420","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1016\/S0968-0896(00)00206-6","article-title":"Novel ferrocenic artemisinin derivatives: synthesis, in vitro antimalarial activity and affinity of binding with ferroprotoporphyrin IX","volume":"8","author":"Delhaes","year":"2000","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0425","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.bmcl.2017.12.057","article-title":"Synthesis, in vitro antimalarial activities and cytotoxicities of amino-artemisinin-ferrocene derivatives","volume":"28","author":"de Lange","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107510_b0430","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1016\/j.bmcl.2018.08.037","article-title":"Synthesis, antimalarial activities and cytotoxicities of amino-artemisinin-1,2-disubstituted ferrocene hybrids","volume":"28","author":"de Lange","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107510_b0435","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejmech.2015.04.053","article-title":"New efficient artemisinin derived agents against human leukemia cells, human cytomegalovirus and Plasmodium falciparum: 2nd generation 1,2,4-trioxane-ferrocene hybrids","volume":"97","author":"Reiter","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0440","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/slct.202004710","article-title":"Hybrid Compounds Containing a Ferrocene Scaffold as Potential Antimalarials","volume":"6","author":"Peter","year":"2021","journal-title":"ChemistrySelect."},{"key":"10.1016\/j.bioorg.2024.107510_b0445","article-title":"Investigation of bioorganometallic artemisinins as antiplasmodials","volume":"987\u2013988","author":"Albertyn","year":"2023","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0450","doi-asserted-by":"crossref","first-page":"15786","DOI":"10.1039\/D3DT02254D","article-title":"Investigation of new ferrocenyl-artesunate derivatives as antiparasitics","volume":"52","author":"Munnik","year":"2023","journal-title":"Dalt. Trans."},{"key":"10.1016\/j.bioorg.2024.107510_b0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2021.111408","article-title":"Bioactive half-sandwich Rh and Ir bipyridyl complexes containing artemisinin","volume":"219","author":"Chellan","year":"2021","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.bioorg.2024.107510_b0460","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1021\/jm400288z","article-title":"Pyridine-Substituted Desoxyritonavir Is a More Potent Inhibitor of Cytochrome P450 3A4 than Ritonavir","volume":"56","author":"Sevrioukova","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0465","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1056\/NEJMra022219","article-title":"Selective Estrogen-Receptor Modulators \u2014 Mechanisms of Action and Application to Clinical Practice","volume":"348","author":"Riggs","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioorg.2024.107510_b0470","doi-asserted-by":"crossref","unstructured":"E.M. Scholar, Tamoxifen, in: S.J. Enna, D.B. Bylund (Eds.), XPharm Compr. Pharmacol. Ref., Elsevier, 2010: pp. 1\u20138. https:\/\/doi.org\/10.1016\/B978-008055232-3.62712-6.","DOI":"10.1016\/B978-008055232-3.62712-6"},{"key":"10.1016\/j.bioorg.2024.107510_b0475","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1590\/0074-02760150163","article-title":"Antiplasmodial activity of iron(II) and ruthenium(II) organometallic complexes against Plasmodium falciparum blood parasites","volume":"110","author":"de Souza","year":"2015","journal-title":"Mem. Inst. Oswaldo Cruz."},{"key":"10.1016\/j.bioorg.2024.107510_b0480","doi-asserted-by":"crossref","first-page":"10078","DOI":"10.1002\/chem.201801090","article-title":"Organometallic Conjugates of the Drug Sulfadoxine for Combatting Antimicrobial Resistance","volume":"24","author":"Chellan","year":"2018","journal-title":"Chem. \u2013 A Eur. J."},{"key":"10.1016\/j.bioorg.2024.107510_b0485","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.634640","article-title":"The Prospective Synergy of Antitubercular Drugs With NAD Biosynthesis Inhibitors","volume":"11","author":"Rohde","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bioorg.2024.107510_b0490","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jinorgbio.2017.04.014","article-title":"Ferrocenyl and organic novobiocin derivatives: Synthesis and their in vitro biological activity","volume":"172","author":"Mbaba","year":"2017","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.bioorg.2024.107510_b0495","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00775-018-1634-9","article-title":"Novobiocin\u2013ferrocene conjugates possessing anticancer and antiplasmodial activity independent of HSP90 inhibition","volume":"24","author":"Mbaba","year":"2019","journal-title":"J. Biol. Inorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0500","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3136\/fstr.19.113","article-title":"Oleanolic acid and ursolic acid in commercial dried fruits","volume":"19","author":"Zhang","year":"2013","journal-title":"Food Sci. Technol. Res."},{"key":"10.1016\/j.bioorg.2024.107510_b0505","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1021\/jm100117e","article-title":"Trioxaferroquines as New Hybrid Antimalarial Drugs","volume":"53","author":"Bellot","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0510","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ejmech.2016.09.044","article-title":"4-Aminoquinoline-ferrocenyl-chalcone conjugates: Synthesis and anti-plasmodial evaluation","volume":"125","author":"Singh","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0515","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ejmech.2014.08.053","article-title":"1H\u20131,2,3-triazole tethered mono- and bis-ferrocenylchalcone-\u03b2-lactam conjugates: Synthesis and antimalarial evaluation","volume":"86","author":"Kumar","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0520","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.ejmech.2014.10.024","article-title":"1H\u20131,2,3-triazole tethered isatin-ferrocene conjugates: Synthesis and in vitro antimalarial evaluation","volume":"87","author":"Kumar","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0525","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ejmech.2014.01.043","article-title":"Synthesis and study of cytotoxic activity of 1,2,4-trioxane- and egonol-derived hybrid molecules against Plasmodium falciparum and multidrug-resistant human leukemia cells","volume":"75","author":"Reiter","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0530","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.3390\/molecules26051333","article-title":"Coumarin-annulated ferrocenyl 1,3-oxazine derivatives possessing in vitro antimalarial and antitrypanosomal potency","volume":"26","author":"Mbaba","year":"2021","journal-title":"Molecules."},{"key":"10.1016\/j.bioorg.2024.107510_b0535","doi-asserted-by":"crossref","first-page":"10387","DOI":"10.1021\/jm300831b","article-title":"Mimicking the intramolecular hydrogen bond: synthesis, biological evaluation, and molecular modeling of benzoxazines and quinazolines as potential antimalarial agents","volume":"55","author":"Gemma","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0540","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1002\/cbic.202000132","article-title":"The in Vitro antiplasmodial and antiproliferative activity of new ferrocene-based \u03b1-aminocresols targeting hemozoin inhibition and DNA interaction","volume":"21","author":"Mbaba","year":"2020","journal-title":"Chembiochem."},{"key":"10.1016\/j.bioorg.2024.107510_b0545","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejmech.2019.06.069","article-title":"Bioisosteric ferrocenyl aminoquinoline-benzimidazole hybrids: Antimicrobial evaluation and mechanistic insights","volume":"180","author":"Baartzes","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0550","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00044-016-1769-6","article-title":"Synthesis of an organo-ruthenium aminoquinoline-trioxane hybrid and evaluation of its activity against Plasmodium falciparum and its toxicity toward normal mammalian cells","volume":"26","author":"Mart\u00ednez","year":"2017","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2024.107510_b0555","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jinorgbio.2018.11.018","article-title":"Evaluation of PTA-derived ruthenium(II) and iridium(III) quinoline complexes against chloroquine-sensitive and resistant strains of the Plasmodium falciparum malaria parasite","volume":"191","author":"Stringer","year":"2019","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.bioorg.2024.107510_b0560","doi-asserted-by":"crossref","first-page":"11543","DOI":"10.1039\/D0DT01935F","article-title":"Quinoline-triazole half-sandwich iridium(iii) complexes: synthesis, antiplasmodial activity and preliminary transfer hydrogenation studies","volume":"49","author":"Melis","year":"2020","journal-title":"Dalt. Trans."},{"key":"10.1016\/j.bioorg.2024.107510_b0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112694","article-title":"Antimicrobial evaluation of neutral and cationic iridium(III) and rhodium(III) aminoquinoline-benzimidazole hybrid complexes","volume":"206","author":"Baartzes","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.jorganchem.2022.122419","article-title":"Heteroleptic Rh(III) phenylpyridyl complexes based on an aminoquinoline-benzimidazole hybrid scaffold: Antiplasmodial evaluation and mechanistic insights","volume":"975","author":"Baartzes","year":"2022","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0575","doi-asserted-by":"crossref","first-page":"5791","DOI":"10.1021\/om300334z","article-title":"Exploring the versatility of cycloplatinated thiosemicarbazones as antitumor and antiparasitic agents","volume":"31","author":"Chellan","year":"2012","journal-title":"Organometallics."},{"key":"10.1016\/j.bioorg.2024.107510_b0580","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1039\/b924677k","article-title":"Cysteine proteases as targets for metal-based drugs","volume":"2","author":"Fricker","year":"2010","journal-title":"Metallomics."},{"key":"10.1016\/j.bioorg.2024.107510_b0585","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1039\/c3dt32740j","article-title":"The synthesis and antiparasitic activity of aryl- and ferrocenyl-derived thiosemicarbazone ruthenium(ii)\u2013arene complexes","volume":"42","author":"Adams","year":"2013","journal-title":"Dalt. Trans."},{"key":"10.1016\/j.bioorg.2024.107510_b0590","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jorganchem.2013.04.017","article-title":"Heterobimetallic ferrocenylthiosemicarbazone palladium(II) complexes: Synthesis, electrochemistry and antiplasmodial evaluation","volume":"739","author":"Adams","year":"2013","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0595","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/j.jorganchem.2010.06.010","article-title":"Cyclopalladated complexes containing tridentate thiosemicarbazone ligands of biological significance: Synthesis, structure and antimalarial activity","volume":"695","author":"Chellan","year":"2010","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0600","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jorganchem.2013.02.024","article-title":"Synthesis, characterization and antiplasmodial evaluation of cyclopalladated thiosemicarbazone complexes","volume":"736","author":"Adams","year":"2013","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0605","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1039\/C4DT03234A","article-title":"Improved antiparasitic activity by incorporation of organosilane entities into half-sandwich ruthenium(ii) and rhodium(iii) thiosemicarbazone complexes","volume":"44","author":"Adams","year":"2015","journal-title":"Dalt. Trans."},{"key":"10.1016\/j.bioorg.2024.107510_b0610","doi-asserted-by":"crossref","first-page":"5514","DOI":"10.1039\/C5DT04918K","article-title":"Cyclopalladated organosilane\u2013tethered thiosemicarbazones: novel strategies for improving antiplasmodial activity","volume":"45","author":"Adams","year":"2016","journal-title":"Dalt. Trans."},{"key":"10.1016\/j.bioorg.2024.107510_b0615","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1016\/j.jorganchem.2011.07.028","article-title":"Ferrocenylthiosemicarbazones conjugated to a poly(propyleneimine) dendrimer scaffold: Synthesis and in vitro antimalarial activity","volume":"696","author":"Khanye","year":"2011","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0620","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jorganchem.2016.06.032","article-title":"Mono- and polynuclear ferrocenylthiosemicarbazones: Synthesis, characterisation and antimicrobial evaluation","volume":"819","author":"Baartzes","year":"2016","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0625","article-title":"Exploring the antimalarial and antioxidant efficacy of transition metal(II) chelates of thiosemicarbazone ligands: spectral investigations, molecular docking, DFT, MESP and ADMET","author":"Devi","year":"2023","journal-title":"BioMetals."},{"key":"10.1016\/j.bioorg.2024.107510_b0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.inoche.2023.111674","article-title":"Exploring the antimalarial, antioxidant, anti-inflammatory activities of newly synthesized transition metal(II) complexes bearing thiosemicarbazone ligands: Insights from molecular docking, DFT, MESP and ADMET studies","volume":"159","author":"Kumar","year":"2024","journal-title":"Inorg. Chem. Commun."},{"key":"10.1016\/j.bioorg.2024.107510_b0635","doi-asserted-by":"crossref","first-page":"13","DOI":"10.9734\/ajrimps\/2023\/v12i1206","article-title":"A review on benzothiazole derivatives and their biological significances","author":"Mahapatra","year":"2023","journal-title":"Asian J. Res. Med. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2024.107510_b0640","series-title":"Benzimidazole","article-title":"Benzimidazole: pharmacological profile","author":"Thatikayala","year":"2022"},{"key":"10.1016\/j.bioorg.2024.107510_b0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174027","article-title":"Benzimidazole based hybrids against complex diseases: A catalogue of the SAR profile","volume":"899","author":"Choudhary","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2024.107510_b0650","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.inoche.2013.06.019","article-title":"Organometallic benzimidazoles: Synthesis, characterization and antimalarial activity","volume":"35","author":"Toro","year":"2013","journal-title":"Inorg. Chem. Commun."},{"key":"10.1016\/j.bioorg.2024.107510_b0655","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejmech.2018.10.019","article-title":"Structure-activity relationship studies of antiplasmodial cyclometallated ruthenium(II), rhodium(III) and iridium(III) complexes of 2-phenylbenzimidazoles","volume":"161","author":"Rylands","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0660","doi-asserted-by":"crossref","DOI":"10.1016\/j.jorganchem.2022.122273","article-title":"Investigating the antiplasmodial activity of substituted cyclopentadienyl rhodium and iridium complexes of 2-(2-pyridyl)benzimidazole","volume":"962","author":"Jordaan","year":"2022","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0665","doi-asserted-by":"crossref","DOI":"10.1016\/j.ica.2022.121039","article-title":"Synthesis and study of organometallic PGM complexes containing 2-(2-pyridyl)benzimidazole as antiplasmodial agents","volume":"540","author":"Munnik","year":"2022","journal-title":"Inorganica Chim. Acta."},{"key":"10.1016\/j.bioorg.2024.107510_b0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112215","article-title":"Chalcone hybrids as privileged scaffolds in antimalarial drug discovery: A key review","volume":"193","author":"Qin","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0675","doi-asserted-by":"crossref","first-page":"36035","DOI":"10.1039\/D3RA05361J","article-title":"Chalcone Mannich base derivatives: synthesis, antimalarial activities against Plasmodium knowlesi, and molecular docking analysis","volume":"13","author":"Syahri","year":"2023","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2024.107510_b0680","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1515\/pac-2018-0802","article-title":"Perspectives of ferrocenyl chalcones: synthetic scaffolds toward biomedical and materials science applications","volume":"91","author":"Montes-Gonz\u00e1lez","year":"2019","journal-title":"Pure Appl. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0685","doi-asserted-by":"crossref","first-page":"34377","DOI":"10.1021\/acsomega.3c01830","article-title":"Synthesis of Novel Heterocyclic Ferrocenyl Chalcones and Their Biological Evaluation","volume":"8","author":"Alsina-S\u00e1nchez","year":"2023","journal-title":"ACS Omega."},{"key":"10.1016\/j.bioorg.2024.107510_b0690","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/j.bmc.2011.01.048","article-title":"Ferrocenyl chalcones versus organic chalcones: A comparative study of their nematocidal activity","volume":"19","author":"Attar","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0695","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s00044-016-1509-y","article-title":"Synthesis and in vitro biological activities of ferrocenyl\u2013chalcone amides","volume":"25","author":"Smit","year":"2016","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2024.107510_b0700","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jorganchem.2012.08.024","article-title":"Cyrhetrenyl chalcones: Synthesis, characterization and antimalarial evaluation","volume":"723","author":"Arancibia","year":"2013","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0705","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.molstruc.2014.12.070","article-title":"Ferrocenyl-cymantrenyl hetero-bimetallic chalcones: Synthesis, structure and biological properties","volume":"1085","author":"Mishra","year":"2015","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2024.107510_b0710","doi-asserted-by":"crossref","first-page":"12722","DOI":"10.1021\/acs.inorgchem.0c01795","article-title":"Half-Sandwich Cyclopentadienylruthenium(II) Complexes: A New Antimalarial Chemotype","volume":"59","author":"Milheiro","year":"2020","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0715","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1021\/acs.jmedchem.8b00760","article-title":"Polypharmacology by Design: A Medicinal Chemist\u2019s Perspective on Multitargeting Compounds","volume":"62","author":"Proschak","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0720","doi-asserted-by":"crossref","first-page":"0066","DOI":"10.1038\/s41570-017-0066","article-title":"The medicinal chemistry of ferrocene and its derivatives","volume":"1","author":"Patra","year":"2017","journal-title":"Nat. Rev. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0725","first-page":"1","article-title":"Recent updates in the development of mettallocenes with antimalarial activity, Facta Univ. - Ser. Physics","volume":"18","author":"Aksic","year":"2020","journal-title":"Chem. Technol."},{"key":"10.1016\/j.bioorg.2024.107510_b0730","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.3390\/molecules13112900","article-title":"Ferroquine, an Ingenious Antimalarial Drug \u2013Thoughts on the Mechanism of Action","volume":"13","author":"Dubar","year":"2008","journal-title":"Molecules."},{"key":"10.1016\/j.bioorg.2024.107510_b0735","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1517\/13543784.9.8.1815","article-title":"Artemisinin drugs: novel antimalarial agents","volume":"9","author":"Price","year":"2000","journal-title":"Expert Opin. Investig. Drugs."},{"key":"10.1016\/j.bioorg.2024.107510_b0740","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0140-6736(93)90362-K","article-title":"Qinghaosu","volume":"341","author":"Hien","year":"1993","journal-title":"Lancet."},{"key":"10.1016\/j.bioorg.2024.107510_b0745","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.eng.2018.11.011","article-title":"Artemisinin, the magic drug discovered from traditional chinese medicine","volume":"5","author":"Wang","year":"2019","journal-title":"Engineering."},{"key":"10.1016\/j.bioorg.2024.107510_b0750","doi-asserted-by":"crossref","first-page":"16192","DOI":"10.1074\/jbc.273.26.16192","article-title":"The Plasmodium falciparum Translationally Controlled Tumor Protein Homolog and Its Reaction with the Antimalarial Drug Artemisinin","volume":"273","author":"Bhisutthibhan","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2024.107510_b0755","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/nature01813","article-title":"Artemisinins target the SERCA of Plasmodium falciparum","volume":"424","author":"Eckstein-Ludwig","year":"2003","journal-title":"Nature."},{"key":"10.1016\/j.bioorg.2024.107510_b0760","series-title":"Annu. Reports Med. Chem.","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/bs.armc.2019.05.002","article-title":"The hybrid antimalarial approach","author":"Gupta","year":"2019"},{"key":"10.1016\/j.bioorg.2024.107510_b0765","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1021\/ar7000843","article-title":"Hybrid molecules with a dual mode of action: dream or reality?","volume":"41","author":"Meunier","year":"2008","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.bioorg.2024.107510_b0770","doi-asserted-by":"crossref","first-page":"5469","DOI":"10.1039\/c3ra42513d","article-title":"Diversification in the synthesis of antimalarial trioxane and tetraoxane analogs","volume":"4","author":"Yadav","year":"2014","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2024.107510_b0775","doi-asserted-by":"crossref","first-page":"e1000402","DOI":"10.1371\/journal.pmed.1000406","article-title":"A research agenda for malaria eradication: drugs","volume":"8","author":"Alonso","year":"2011","journal-title":"PLoS Med."},{"key":"10.1016\/j.bioorg.2024.107510_b0780","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1128\/AAC.00967-06","article-title":"Trioxaquines are new antimalarial agents active on all erythrocytic forms, including gametocytes","volume":"51","author":"Benoit-Vical","year":"2007","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824004152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824004152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T01:18:46Z","timestamp":1718414326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206824004152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":156,"alternative-id":["S0045206824004152"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107510","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring antimalarial potential: Conjugating organometallic moieties with organic fragments for enhanced efficacy","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107510","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107510"}}